30th March 2011 - Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Galantamine Tablets USP 4mg, 8mg and 12mgGalantamine Tablets USP 4mg, 8mg and 12mg is the generic version of Ortho McNeil Janssen Pharmaceutical, Inc's Razadyne® Tablets 4mg, 8mg and 12mg. The product falls under the neurological (CNS) therapeutic category and is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. The product has a market size of approximately US$ 41 million for the twelve months ending September 2010 according to IMS and will be launched shortly... Aurobindo Pharma's Press Release -
